Dr. Roy Beveridge is Humana’s Senior Vice President and Chief Medical Officer, where he is responsible for developing and implementing the company’s clinical strategy and advancing its integrated care delivery model. He is known for creating collaborative environments among physician communities and providing thought leadership, publishing extensively in the fields of medical oncology, quality design, ethics, and population health. Previously, Dr. Beveridge served as Chief Medical Officer for McKesson Specialty Health and as Executive VP and Chief Medical Officer for US Oncology. He practiced for more than 20 years in medical oncology and stem cell transplant in northern Virginia.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: Precision Medicine’s value is undeniable. But what about its financial impact? And how should we assess its value beyond the field of oncology? This session will cover the unsustainable economics at play, reimbursement challenges and policies, and cost-based pricing versus value-based pricing, from a patient, pharma, payor, and molecular diagnostics perspective.